- Home
- VUZI vs XGN Comparison
VUZI vs XGN Comparison
Compare VUZI & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VUZI
- XGN
- Stock Information
- Founded
- VUZI 1997
- XGN 2002
- Country
- VUZI United States
- XGN United States
- Employees
- VUZI N/A
- XGN N/A
- Industry
- VUZI Industrial Machinery/Components
- XGN Medical Specialities
- Sector
- VUZI Technology
- XGN Health Care
- Exchange
- VUZI Nasdaq
- XGN Nasdaq
- Market Cap
- VUZI 236.4M
- XGN 138.3M
- IPO Year
- VUZI N/A
- XGN 2019
- Fundamental
- Price
- VUZI $2.73
- XGN $6.99
- Analyst Decision
- VUZI Strong Buy
- XGN Strong Buy
- Analyst Count
- VUZI 1
- XGN 2
- Target Price
- VUZI $2.00
- XGN $7.50
- AVG Volume (30 Days)
- VUZI 2.1M
- XGN 228.1K
- Earning Date
- VUZI 08-13-2025
- XGN 08-04-2025
- Dividend Yield
- VUZI N/A
- XGN N/A
- EPS Growth
- VUZI N/A
- XGN N/A
- EPS
- VUZI N/A
- XGN N/A
- Revenue
- VUZI $5,331,630.00
- XGN $56,724,000.00
- Revenue This Year
- VUZI $45.35
- XGN $19.39
- Revenue Next Year
- VUZI $54.01
- XGN $13.27
- P/E Ratio
- VUZI N/A
- XGN N/A
- Revenue Growth
- VUZI N/A
- XGN 1.78
- 52 Week Low
- VUZI $0.83
- XGN $1.71
- 52 Week High
- VUZI $5.79
- XGN $7.95
- Technical
- Relative Strength Index (RSI)
- VUZI 47.11
- XGN 52.04
- Support Level
- VUZI $2.71
- XGN $6.62
- Resistance Level
- VUZI $3.16
- XGN $7.38
- Average True Range (ATR)
- VUZI 0.19
- XGN 0.49
- MACD
- VUZI -0.06
- XGN -0.09
- Stochastic Oscillator
- VUZI 7.94
- XGN 28.89
About VUZI Vuzix Corporation
Vuzix Corp is engaged in the design, manufacture, and marketing of Artificial Intelligence (AI)-powered Smart Glasses, Waveguides, and Augmented Reality (AR) technologies. Its solutions serve the enterprise, medical, defense, security, and select consumer markets, offering cutting-edge wearable computing and display technologies that enhance productivity and operational efficiency. Its products include near-eye displays (NEDs), heads-up displays (HUDs), and wearable computing devices. Geographically, the company generates a majority of its revenue from the United States and also has a presence in Japan, the Netherlands, and other countries.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.